Work

Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330

Year: 2018

Type: article

Abstract: Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and

Source: Haematologica

DOI: 10.3324/haematol.2018.202069

Authors: George S. Laszlo, Mary E. Beddoe, Colin D. Godwin, Olivia M. Bates, Chelsea J. Gudgeon, Kimberly H. Harrington, Roland B. Walter

Institutions: Fred Hutch Cancer Center, University of Washington

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: National Cancer Research Institute, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G834931733, Cancer Center Support Grant

OpenAlex ID: W2887803091

FWCI: 1.368

Cites: 18

Cited by: 23

Related to: 10